Novoris (Risperidone)

Risperidone, the active ingredient in Novoris, is an atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia, bipolar I disorder (manic episodes), and irritability associated with autistic disorder in adults and adolescents, helping to control psychotic symptoms, stabilize mood, and reduce aggressive behaviors. The medication works by balancing neurotransmitter activity in the brain, which can improve overall functioning and quality of life.

GNH USA supplies Novoris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Risperidone is an atypical antipsychotic that modulates dopaminergic and serotonergic pathways.

Schizophrenia: alleviates positive and negative symptoms, improving thought processes and social functioning. Bipolar I disorder (manic episodes): stabilizes mood and reduces manic symptoms, helping prevent relapse. Irritability associated with autistic disorder: decreases aggression, self‑injurious behavior and mood swings.

Risperidone may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Weight gain: increase in body mass may occur. - Sedation: drowsiness or fatigue. - Dizziness: light‑headedness, especially when standing. - Increased prolactin: menstrual changes or galactorrhea.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements that may be irreversible. - Neuroleptic malignant syndrome: life‑threatening fever, muscle rigidity and autonomic instability. - Agranulocytosis: severe reduction in white blood cells, increasing infection risk.

When prescribing Risperidone, clinicians should observe several safety considerations.

Monitor metabolic parameters: regularly assess weight, glucose and lipid levels. Assess extrapyramidal symptoms: watch for tremor, rigidity or akathisia. Evaluate cardiac status: consider ECG monitoring for QT prolongation risk. Review pregnancy status: use only if potential benefit outweighs fetal risk. Store at ambient temperature: keep in original container, protect from moisture and light.

Risperidone can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise risperidone plasma concentrations. - Co‑administration with other antipsychotics: increases risk of QT prolongation and extrapyramidal effects. - CNS depressants (e.g., benzodiazepines, alcohol): may enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect may occur. - Anticholinergic agents: can mask early signs of extrapyramidal symptoms. - Smoking: induces CYP1A2, potentially lowering risperidone levels.